Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes

Debra L. Irsik, Melissa J. Romero-Aleshire, Erin M. Chavez, Rachel W. Fallet, Heddwen L. Brooks, Pamela K Carmines, Pascale H. Lane

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Estro-gen has been implicated in the regulation of growth and immune function in the kidney, which expresses the full-length estrogen receptor-α (ERα66), its ERα splice variants, and estrogen receptor-β (ERβ). Thus, we hypothesized that these splice variants may inhibit the glomerular enlargement that occurs early in type 1 diabetes (T1D). T1D was induced by streptozotocin (STZ) injection in 8-to 12-wk-old female mice lacking ERα66 (ERα66KO) or all ERα variants (αERKO), and their wild-type (WT) littermates. Basal renal ERα36 protein expression was reduced in the ERα66KO model and was downregulated by T1D in WT mice. T1D did not alter ERα46 or ERβ in WT-STZ; however, ERα46 was decreased modestly in ERα66KO mice. Renal hypertrophy was evident in all diabetic mice. F4/80-positive immunostaining was reduced in ERα66KO compared with WT and αERKO mice but was higher in STZ than in Control mice across all genotypes. Glomerular area was greater in WT and αERKO than in ERα66KO mice, with T1D-induced glomerular enlargement apparent in WT-STZ and αERKO-STZ, but not in ERα66KO-STZ mice. Proteinuria and hyperfiltration were evident in ERα66KO-STZ and αERKO-STZ, but not in WT-STZ mice. These data indicate that ERα splice variants may exert an inhibitory influence on glomerular enlargement and macrophage infiltration during T1D; however, effects of splice variants are masked in the presence of the full-length ERα66, suggesting that ERα66 acts in opposition to its splice variants to influence these parameters. In contrast, hyperfiltration and proteinuria in T1D are attenuated via an ERα66-dependent mechanism that is unaffected by splice variant status.

Original languageEnglish (US)
Pages (from-to)F512-F520
JournalAmerican Journal of Physiology - Renal Physiology
Volume315
Issue number3
DOIs
StatePublished - Sep 1 2018

Fingerprint

Streptozocin
Type 1 Diabetes Mellitus
Estrogen Receptors
Kidney
Proteinuria
Hypertrophy
Down-Regulation
Macrophages
Genotype
Injections
Growth

Keywords

  • Estrogen receptors
  • Glomeruli
  • Macrophage
  • Type 1 diabetes

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes. / Irsik, Debra L.; Romero-Aleshire, Melissa J.; Chavez, Erin M.; Fallet, Rachel W.; Brooks, Heddwen L.; Carmines, Pamela K; Lane, Pascale H.

In: American Journal of Physiology - Renal Physiology, Vol. 315, No. 3, 01.09.2018, p. F512-F520.

Research output: Contribution to journalArticle

Irsik, Debra L. ; Romero-Aleshire, Melissa J. ; Chavez, Erin M. ; Fallet, Rachel W. ; Brooks, Heddwen L. ; Carmines, Pamela K ; Lane, Pascale H. / Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes. In: American Journal of Physiology - Renal Physiology. 2018 ; Vol. 315, No. 3. pp. F512-F520.
@article{0f0c4e6b3c024f3c9dae48e08e7ec550,
title = "Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes",
abstract = "Estro-gen has been implicated in the regulation of growth and immune function in the kidney, which expresses the full-length estrogen receptor-α (ERα66), its ERα splice variants, and estrogen receptor-β (ERβ). Thus, we hypothesized that these splice variants may inhibit the glomerular enlargement that occurs early in type 1 diabetes (T1D). T1D was induced by streptozotocin (STZ) injection in 8-to 12-wk-old female mice lacking ERα66 (ERα66KO) or all ERα variants (αERKO), and their wild-type (WT) littermates. Basal renal ERα36 protein expression was reduced in the ERα66KO model and was downregulated by T1D in WT mice. T1D did not alter ERα46 or ERβ in WT-STZ; however, ERα46 was decreased modestly in ERα66KO mice. Renal hypertrophy was evident in all diabetic mice. F4/80-positive immunostaining was reduced in ERα66KO compared with WT and αERKO mice but was higher in STZ than in Control mice across all genotypes. Glomerular area was greater in WT and αERKO than in ERα66KO mice, with T1D-induced glomerular enlargement apparent in WT-STZ and αERKO-STZ, but not in ERα66KO-STZ mice. Proteinuria and hyperfiltration were evident in ERα66KO-STZ and αERKO-STZ, but not in WT-STZ mice. These data indicate that ERα splice variants may exert an inhibitory influence on glomerular enlargement and macrophage infiltration during T1D; however, effects of splice variants are masked in the presence of the full-length ERα66, suggesting that ERα66 acts in opposition to its splice variants to influence these parameters. In contrast, hyperfiltration and proteinuria in T1D are attenuated via an ERα66-dependent mechanism that is unaffected by splice variant status.",
keywords = "Estrogen receptors, Glomeruli, Macrophage, Type 1 diabetes",
author = "Irsik, {Debra L.} and Romero-Aleshire, {Melissa J.} and Chavez, {Erin M.} and Fallet, {Rachel W.} and Brooks, {Heddwen L.} and Carmines, {Pamela K} and Lane, {Pascale H.}",
year = "2018",
month = "9",
day = "1",
doi = "10.1152/ajprenal.00231.2017",
language = "English (US)",
volume = "315",
pages = "F512--F520",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes

AU - Irsik, Debra L.

AU - Romero-Aleshire, Melissa J.

AU - Chavez, Erin M.

AU - Fallet, Rachel W.

AU - Brooks, Heddwen L.

AU - Carmines, Pamela K

AU - Lane, Pascale H.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Estro-gen has been implicated in the regulation of growth and immune function in the kidney, which expresses the full-length estrogen receptor-α (ERα66), its ERα splice variants, and estrogen receptor-β (ERβ). Thus, we hypothesized that these splice variants may inhibit the glomerular enlargement that occurs early in type 1 diabetes (T1D). T1D was induced by streptozotocin (STZ) injection in 8-to 12-wk-old female mice lacking ERα66 (ERα66KO) or all ERα variants (αERKO), and their wild-type (WT) littermates. Basal renal ERα36 protein expression was reduced in the ERα66KO model and was downregulated by T1D in WT mice. T1D did not alter ERα46 or ERβ in WT-STZ; however, ERα46 was decreased modestly in ERα66KO mice. Renal hypertrophy was evident in all diabetic mice. F4/80-positive immunostaining was reduced in ERα66KO compared with WT and αERKO mice but was higher in STZ than in Control mice across all genotypes. Glomerular area was greater in WT and αERKO than in ERα66KO mice, with T1D-induced glomerular enlargement apparent in WT-STZ and αERKO-STZ, but not in ERα66KO-STZ mice. Proteinuria and hyperfiltration were evident in ERα66KO-STZ and αERKO-STZ, but not in WT-STZ mice. These data indicate that ERα splice variants may exert an inhibitory influence on glomerular enlargement and macrophage infiltration during T1D; however, effects of splice variants are masked in the presence of the full-length ERα66, suggesting that ERα66 acts in opposition to its splice variants to influence these parameters. In contrast, hyperfiltration and proteinuria in T1D are attenuated via an ERα66-dependent mechanism that is unaffected by splice variant status.

AB - Estro-gen has been implicated in the regulation of growth and immune function in the kidney, which expresses the full-length estrogen receptor-α (ERα66), its ERα splice variants, and estrogen receptor-β (ERβ). Thus, we hypothesized that these splice variants may inhibit the glomerular enlargement that occurs early in type 1 diabetes (T1D). T1D was induced by streptozotocin (STZ) injection in 8-to 12-wk-old female mice lacking ERα66 (ERα66KO) or all ERα variants (αERKO), and their wild-type (WT) littermates. Basal renal ERα36 protein expression was reduced in the ERα66KO model and was downregulated by T1D in WT mice. T1D did not alter ERα46 or ERβ in WT-STZ; however, ERα46 was decreased modestly in ERα66KO mice. Renal hypertrophy was evident in all diabetic mice. F4/80-positive immunostaining was reduced in ERα66KO compared with WT and αERKO mice but was higher in STZ than in Control mice across all genotypes. Glomerular area was greater in WT and αERKO than in ERα66KO mice, with T1D-induced glomerular enlargement apparent in WT-STZ and αERKO-STZ, but not in ERα66KO-STZ mice. Proteinuria and hyperfiltration were evident in ERα66KO-STZ and αERKO-STZ, but not in WT-STZ mice. These data indicate that ERα splice variants may exert an inhibitory influence on glomerular enlargement and macrophage infiltration during T1D; however, effects of splice variants are masked in the presence of the full-length ERα66, suggesting that ERα66 acts in opposition to its splice variants to influence these parameters. In contrast, hyperfiltration and proteinuria in T1D are attenuated via an ERα66-dependent mechanism that is unaffected by splice variant status.

KW - Estrogen receptors

KW - Glomeruli

KW - Macrophage

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85052976791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052976791&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00231.2017

DO - 10.1152/ajprenal.00231.2017

M3 - Article

VL - 315

SP - F512-F520

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 3

ER -